Anteris Technologies Global Corp. — Director's Dealing 2008

Jan 10, 2008

Innovative BioMedical Devices bioMD Limited ABN 35 088 221 078

Level 11, 225 St Georges Terrace Perth, Western Australia 6000 PO Box 7209, Cloisters Square Western Australia 6850

Telephone (08) 9262 6777 Facsimile (08) 9322 3433 www.biomd.com.au

==> picture [50 x 33] intentionally omitted <==

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 2 pages

11 January 2008

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam

Re: Appendix 3Y – Change in Director’s Interest Notice

The Directors of bioMD Ltd wish to advise of changes to the notifiable interests of a director, in accordance with Listing Rule 3.19A.1 and section 205G of the Corporations Act.

Please refer to the ‘Appendix 3Y’ attached for details of the change in holding.

Yours faithfully

==> picture [114 x 85] intentionally omitted <==

CAROLINE L BENTLEY Company Secretary

APPENDIX 3Y CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 055 221 078

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Robert Towner

Date of last notice: 17 December 2007

PART 1 – Change of director's relevant interests in securities Direct or indirect interest: Direct / Indirect Nature of indirect interest: Mr Towner is a director of a company holding BOD Date of change: 10 January 2008

No. of securities held prior to change: Ordinary shares–11,065,000 (indirect), 396,677 (direct)

Class:	Listed ordinary shares (BOD)
	Options expiring 30 Aug 2010 at 25 cents each
Number acquired:	20,000 shares (indirect)
Number disposed:	N/A
Value/Consideration:	$2,500
**No. of securities held after change:**Ordinary shares–11,085,000 (indirect)
	396,677 (direct)
Nature of the change:	On market purchase

PART 2 – Change of director’s interests in contracts

Details of contract: None Applicable Nature of interest: Name of registered holder: (if issued securities) No. and class of securities to which interest relates: Interest acquired: Interest disposed: Value/Consideration: Interest after change: